Routes of
administration Oral ChemSpider 117369 3D model (Jmol) Interactive image | ATC code none Formula C28H35F3N2O2 Molar mass 488.58 g/mol | |
 | ||
FCE-28260 is an azasteroidal 5α-reductase inhibitor which was developed for the treatment of benign prostatic hyperplasia and androgenic alopecia (pattern hair loss) in the 1990s but was never marketed. FCE-28260 has been found to inhibit rat and human 5α-reductase with half-maximal inhibitory concentrations (IC50) of 15 and 16 nM, respectively, while finasteride had values of 30 and 52 nM.
References
FCE-28260 Wikipedia(Text) CC BY-SA